The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effects of prexasertib, a CHK1 inhibitor, in the immune microenvironment of head and neck squamous cell carcinoma (HNSCC).
 
Ritu Chaudhary
No Relationships to Disclose
 
Robbert Slebos
Consulting or Advisory Role - Bristol-Myers Squibb (I); Cue Biopharma (I); Ignyta (I); Mirati Therapeutics (I)
Research Funding - AstraZeneca (I); Bristol-Myers Squibb (I); Ignyta (I); IRX Therapeutics (I); Lilly (I); Merck (I); Regeneron (I)
Travel, Accommodations, Expenses - AstraZeneca (I); Mirati Therapeutics (I)
 
Feifei Song
No Relationships to Disclose
 
Keegan McCleary-Sharpe
No Relationships to Disclose
 
Jude Masannat
No Relationships to Disclose
 
Aik Choon Tan
Employment - Firma Clinical Research (I)
Patents, Royalties, Other Intellectual Property - University of Colorado Anschutz Medical Campus
 
Xuefeng Wang
No Relationships to Disclose
 
Nelusha Amaladas
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Wenjuan Wu
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
Travel, Accommodations, Expenses - Lilly
 
Gerald Hall
Employment - Lilly
Stock and Other Ownership Interests - Lilly
Research Funding - Lilly
 
Christine H. Chung
Consulting or Advisory Role - Bristol-Myers Squibb; CUE Biopharma; Ignyta; Mirati Therapeutics
Research Funding - AstraZeneca; Bristol-Myers Squibb; Ignyta; IRX Therapeutics; Lilly; Lion Biotechnologies; Merck; Pfizer; Regeneron
Travel, Accommodations, Expenses - AstraZeneca; Mirati Therapeutics